
Mark S. Rushing
Examiner (ID: 596)
| Most Active Art Unit | 2685 |
| Art Unit(s) | 2685, 2736, 2689, 2612, 2681, 2687, 2686, 4182, 2682, 2617 |
| Total Applications | 1006 |
| Issued Applications | 769 |
| Pending Applications | 59 |
| Abandoned Applications | 196 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20220940
[patent_doc_number] => 20250283871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => COMPOSITIONS AND METHODS FOR MODULATING THE INTERACTION BETWEEN SS18-SSX FUSION ONCOPROTEIN AND NUCLEOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/905875
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 117335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905875
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905875 | COMPOSITIONS AND METHODS FOR MODULATING THE INTERACTION BETWEEN SS18-SSX FUSION ONCOPROTEIN AND NUCLEOSOMES | Jan 20, 2021 | Pending |
Array
(
[id] => 16824588
[patent_doc_number] => 20210139881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => IMMOBILIZED PROTEINS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/152074
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/152074 | IMMOBILIZED PROTEINS AND USE THEREOF | Jan 18, 2021 | Abandoned |
Array
(
[id] => 16963263
[patent_doc_number] => 20210214762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => ARTIFICIAL ORGANELLES FOR ENZYMATIC COFACTOR REDUCTION
[patent_app_type] => utility
[patent_app_number] => 17/143755
[patent_app_country] => US
[patent_app_date] => 2021-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17143755
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/143755 | Artificial organelles for enzymatic cofactor reduction | Jan 6, 2021 | Issued |
Array
(
[id] => 18628463
[patent_doc_number] => 20230287327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => GLYCOENGINEERING USING LEISHMANIA CELLS
[patent_app_type] => utility
[patent_app_number] => 17/791011
[patent_app_country] => US
[patent_app_date] => 2021-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/791011 | GLYCOENGINEERING USING LEISHMANIA CELLS | Jan 6, 2021 | Pending |
Array
(
[id] => 16870450
[patent_doc_number] => 20210163917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => ENZYME FORMULATION AND METHOD FOR DEGRADATION
[patent_app_type] => utility
[patent_app_number] => 17/116978
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116978 | ENZYME FORMULATION AND METHOD FOR DEGRADATION | Dec 8, 2020 | Abandoned |
Array
(
[id] => 19810456
[patent_doc_number] => 12241839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Multipartite luciferase peptides and polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/105925
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 259
[patent_figures_cnt] => 297
[patent_no_of_words] => 92611
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105925 | Multipartite luciferase peptides and polypeptides | Nov 26, 2020 | Issued |
Array
(
[id] => 16712192
[patent_doc_number] => 20210079339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => FERMENTATION PRODUCTION PROCESS OF PAECILOMYCES HEPIALIS CS-4
[patent_app_type] => utility
[patent_app_number] => 17/105438
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105438
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105438 | FERMENTATION PRODUCTION PROCESS OF PAECILOMYCES HEPIALIS CS-4 | Nov 24, 2020 | Abandoned |
Array
(
[id] => 18143511
[patent_doc_number] => 20230017360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/778655
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778655 | Kit for preparing nanoparticle composition for drug delivery | Nov 18, 2020 | Issued |
Array
(
[id] => 16671303
[patent_doc_number] => 20210060066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => COMPOSITIONS AND METHODS FOR PLATELET ENRICHED FIBRIN CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 16/950464
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950464
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950464 | COMPOSITIONS AND METHODS FOR PLATELET ENRICHED FIBRIN CONSTRUCTS | Nov 16, 2020 | Abandoned |
Array
(
[id] => 17200525
[patent_doc_number] => 20210340620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => CELL POTENCY ASSAY FOR THERAPEUTIC POTENTIAL
[patent_app_type] => utility
[patent_app_number] => 17/096787
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096787 | CELL POTENCY ASSAY FOR THERAPEUTIC POTENTIAL | Nov 11, 2020 | Abandoned |
Array
(
[id] => 18806099
[patent_doc_number] => 20230380428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/031856
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031856
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/031856 | BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS | Oct 15, 2020 | Pending |
Array
(
[id] => 16598367
[patent_doc_number] => 20210024898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => OPTICAL-QUALITY SURFACE THAT IMPARTS SPATIAL CONTROL OF MACROPHAGE FUSION
[patent_app_type] => utility
[patent_app_number] => 17/063412
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063412 | Optical-quality surface that imparts spatial control of macrophage fusion | Oct 4, 2020 | Issued |
Array
(
[id] => 19142562
[patent_doc_number] => 20240141405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => COMPOSITION FOR PREDICTING OR DIAGNOSING EARLY-STAGE DIFFUSE GASTRIC CANCER, COMPRISING PREPARATION FOR MEASURING LEVEL OF PEPSINOGEN II
[patent_app_type] => utility
[patent_app_number] => 18/015207
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015207
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015207 | COMPOSITION FOR PREDICTING OR DIAGNOSING EARLY-STAGE DIFFUSE GASTRIC CANCER, COMPRISING PREPARATION FOR MEASURING LEVEL OF PEPSINOGEN II | Sep 16, 2020 | Pending |
Array
(
[id] => 16748847
[patent_doc_number] => 20210100856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT
[patent_app_type] => utility
[patent_app_number] => 17/017469
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/017469 | METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT | Sep 9, 2020 | Pending |
Array
(
[id] => 16671336
[patent_doc_number] => 20210060099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => NUTRITIONAL SUPPLEMENTS AND METHODS OF NUTRITIONAL SUPPLEMENTATION AFFECTING MICROBIOME METABOLISM
[patent_app_type] => utility
[patent_app_number] => 17/013424
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/013424 | NUTRITIONAL SUPPLEMENTS AND METHODS OF NUTRITIONAL SUPPLEMENTATION AFFECTING MICROBIOME METABOLISM | Sep 3, 2020 | Abandoned |
Array
(
[id] => 16977882
[patent_doc_number] => 20210222119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => BACTERIA FOR DEGRADING ETHYLENE OXIDE AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/012810
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012810
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012810 | Bacteria for degrading ethylene oxide and applications thereof | Sep 3, 2020 | Issued |
Array
(
[id] => 18065675
[patent_doc_number] => 20220396762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => GROWING PROGRAMMABLE ENZYME-FUNCTIONALIZED AND SENSE-AND-RESPONSE BACTERIAL CELLULOSE LIVING MATERIALS WITH ENGINEERED MICROBIAL CO-CULTURES
[patent_app_type] => utility
[patent_app_number] => 17/636259
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/636259 | GROWING PROGRAMMABLE ENZYME-FUNCTIONALIZED AND SENSE-AND-RESPONSE BACTERIAL CELLULOSE LIVING MATERIALS WITH ENGINEERED MICROBIAL CO-CULTURES | Aug 20, 2020 | Abandoned |
Array
(
[id] => 16627470
[patent_doc_number] => 20210046123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => METHODS FOR TREATING DISEASE ASSOCIATED WITH SENESCENCE
[patent_app_type] => utility
[patent_app_number] => 16/994356
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/994356 | METHODS FOR TREATING DISEASE ASSOCIATED WITH SENESCENCE | Aug 13, 2020 | Abandoned |
Array
(
[id] => 17258908
[patent_doc_number] => 20210371893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => CELL-FREE PROTEIN SYNTHESIS METHOD
[patent_app_type] => utility
[patent_app_number] => 17/265527
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 333
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265527
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265527 | CELL-FREE PROTEIN SYNTHESIS METHOD | Aug 6, 2020 | Abandoned |
Array
(
[id] => 16435732
[patent_doc_number] => 20200353057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => REDUCING IMMUNOGENICITY TO PEGLOTICASE
[patent_app_type] => utility
[patent_app_number] => 16/942569
[patent_app_country] => US
[patent_app_date] => 2020-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16942569
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/942569 | REDUCING IMMUNOGENICITY TO PEGLOTICASE | Jul 28, 2020 | Abandoned |